We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Christopher L. Nelson is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2006 — 2007 |
Nelson, Christopher L |
F32Activity Code Description: To provide postdoctoral research training to individuals to broaden their scientific background and extend their potential for research in specified health-related areas. |
Cellular Plasticity Following Repeated Amphetamine @ Rosalind Franklin Univ of Medicine &Sci
[unreadable] DESCRIPTION (provided by applicant): [unreadable] The underlying cellular and neurochemical mechanisms by which drugs modify the brain are a critical target of research designed to provide potential treatment strategies for addicted patients. Our hypothesis is that an essential component of addiction is aberrant glutamatergic neuronal plasticity, involving mechanisms common to LTP and LTD. This proposal will test this hypothesis by determining the effect of repeated amphetamine on glutamate receptor trafficking in the nucleus accumbens, a brain region critical for the expression of sensitization to drugs of abuse, and characerizing glutamatergic/cholinergic interactions in the ventral tegmental area, a region critical in the development of sensitization. We propose to investigate glutamate receptor and choline transporter trafficking at the cellular level, and investigate the cholinergic regulation of ventral tegmental excitability using in vivo microdialysis. Together, these approaches will provide a mechanistic link between drug-induced biochemical alterations and glutamatergic neuroplasticity, and will provide biochemical and neurochemical insight into the critical role of the cholinergic system in the regulation of midbrain excitability, and the consequences of aberrant regulation elicited by drugs of abuse. [unreadable] [unreadable] [unreadable] [unreadable] [unreadable]
|
0.903 |